Trademarks = 2

Forward Citations = 15

Loading Chart...

2 inventors (with patents filed for the assignee):

Tennore M Ramesh (4 out of 5 patents)

Sean Scott (4 out of 5 patents)

4 patents: Sort by Forward Citations

1. 7902185 - Treatment of neurodegenerative diseases using proteasome modulators (2011-03-08),

2. 7273888 - Use of difluoromethylornithine (DFMO) for the treatment of amyotrophic lateral sclerosis (2007-09-25),

3. 7211602 - Treatment of neurodegenerative disorders through the modulation of the polyamine pathway (2007-05-01),

4. 7030126 - Use of polyamine analogs for amyotrophic lateral sclerosis (2006-04-18),

ALS Therapy Development Foundation, Inc. is a non-profit biotech organization dedicated to finding effective treatments and a cure for Amyotrophic Lateral Sclerosis (ALS). Through research and collaboration, they strive to accelerate the development of therapies to improve the lives of those affected by ALS. Their work is driven by a sense of urgency and commitment to making a difference in the lives of ALS patients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#378 in Cambridge, MA

#3,235 in Massachusetts

#59,059 in US

Cambridge, MA, United States of America

Als Therapy Development Foundation, Inc.

Forward Citations = 15

2 inventors:

Tennore M Ramesh (4 out of 5 patents)

Sean Scott (4 out of 5 patents)

Please report any incorrect information to support@idiyas.com